🖼

Figure 2 — TFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas: Molecular Landscape and

active
paper figure Created: 2026-04-21T18:29:40 By: paper_figures_tool Quality: 50% 🔗 External ID: paper-fig-paper-41899560-2
Figure 2 — TFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas: Molecular Landscape and
Figure 2Figure 2
Multistep and multiscale model of MiT family-driven renal cell carcinoma. Schematic overview linking initiating genetic events ( TFE3 gene fusions or TFEB gene amplification/rearrangement) to MiT-driven transcriptional reprogramming, cellular consequences, characteristic morphologic patterns, and downstream clinical implications. The diagram integrates molecular alterations with diagnostic pitfalls, clinical heterogeneity, and current therapeutic uncertainty. Arrows indicate progression/relationships between molecular alterations, cellular consequences, tumor phenotype, and clinical implications; colors and icons are schematic and not quantitative. Created in BioRender. Cotaina Recio, M. (2026) https://BioRender.com/8vz33mn (accessed on 12 March 2026).
PubMed: paper-41899560
Metadata
pmidpaper-41899560
captionMultistep and multiscale model of MiT family-driven renal cell carcinoma. Schematic overview linking initiating genetic events ( TFE3 gene fusions or TFEB gene amplification/rearrangement) to MiT-d
image_urlhttps://www.ebi.ac.uk/europepmc/articles/PMC13025244/bin/cancers-18-00958-g002.jpg
paper_titleTFE3-Rearranged and TFEB-Altered Renal Cell Carcinomas: Molecular Landscape and Therapeutic Advances.
figure_labelFigure 2
figure_number2
_schema_version1
source_strategypmc_api
📊 Evidence Profile
Evidence Balance
+0%
Certainty
0%
Debates
0
Incoming
0
Outgoing
0
0 supporting 0 contradicting 0 neutral
View full evidence profile →
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.